Maciej Kmieciak

Department of Microbiology & Immunology, Virginia Commonwealth University- Massey Cancer Center

Affiliated withVirginia Commonwealth University- Massey Cancer Center

Research Area

Immunology and Infection

Biography

Maciej Kmieciak has not added Biography.
If you are Maciej Kmieciak and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 6	2011

Other Publications

Article	Year
Cloning and characterization of two subunits of Arabidopsis thaliana nuclear cap-binding complex. Gene\| PubMed ID: 11867224	2002
[The role of nuclear proteins that bind to 7-methyl-guanosine at the 5' end of RNA]. Postepy biochemii\| PubMed ID: 12362603	2002
Emergence of immune escape variant of mammary tumors that has distinct proteomic profile and a reduced ability to induce "danger signals". Breast cancer research and treatment\| PubMed ID: 16211331	2006
Comment on "Tumor progression can occur despite the induction of very high levels of self/tumor antigen-specific CD8+ T cells in patients with melanoma". Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 16585536	2006
HER-2/neu antigen loss and relapse of mammary carcinoma are actively induced by T cell-mediated anti-tumor immune responses. European journal of immunology\| PubMed ID: 17304628	2007
Tumor immunoediting and immunosculpting pathways to cancer progression. Seminars in cancer biology\| PubMed ID: 17662614	2007
Danger signals and nonself entity of tumor antigen are both required for eliciting effective immune responses against HER-2/neu positive mammary carcinoma: implications for vaccine design. Cancer immunology, immunotherapy : CII\| PubMed ID: 18278493	2008
Signatures associated with rejection or recurrence in HER-2/neu-positive mammary tumors. Cancer research\| PubMed ID: 18381452	2008
Radiofrequency thermal ablation of breast tumors combined with intralesional administration of IL-7 and IL-15 augments anti-tumor immune responses and inhibits tumor development and metastas... Breast cancer research and treatment\| PubMed ID: 18425677	2009
Does HER-2/neu antigen loss in metastatic breast tumors occur under immune pressure? International journal of cancer. Journal international du cancer\| PubMed ID: 18566999	2008
Adoptive transfer of HER2/neu-specific T cells expanded with alternating gamma chain cytokines mediate tumor regression when combined with the depletion of myeloid-derived suppressor cells. Cancer immunology, immunotherapy : CII\| PubMed ID: 18979098	2009
Incubation of antigen-sensitized T lymphocytes activated with bryostatin 1 + ionomycin in IL-7 + IL-15 increases yield of cells capable of inducing regression of melanoma metastases compared... Cancer immunology, immunotherapy : CII\| PubMed ID: 19198835	2009
The Arabidopsis CBP20 targets the cap-binding complex to the nucleus, and is stabilized by CBP80. The Plant journal : for cell and molecular biology\| PubMed ID: 19453442	2009
Human T cells express CD25 and Foxp3 upon activation and exhibit effector/memory phenotypes without any regulatory/suppressor function. Journal of translational medicine\| PubMed ID: 19849846	2009
GM-CSF is one of the main breast tumor-derived soluble factors involved in the differentiation of CD11b-Gr1- bone marrow progenitor cells into myeloid-derived suppressor cells. Breast cancer research and treatment\| PubMed ID: 19898981	2010
CD4+ T cells inhibit the neu-specific CD8+ T-cell exhaustion during the priming phase of immune responses against breast cancer. Breast cancer research and treatment\| PubMed ID: 20480224	2011
Tumor escape and progression of HER-2/neu negative breast cancer under immune pressure. Journal of translational medicine\| PubMed ID: 21453513	2011
A signature of immune function genes associated with recurrence-free survival in breast cancer patients. Breast cancer research and treatment\| PubMed ID: 21479927	2012
Activated NKT cells and NK cells render T cells resistant to myeloid-derived suppressor cells and result in an effective adoptive cellular therapy against breast cancer in the FVBN202 transg... Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 21670315	2011
CD44(+)/CD24(-/low) cancer stem/progenitor cells are more abundant in triple-negative invasive breast carcinoma phenotype and are associated with poor outcome. Human pathology\| PubMed ID: 21835433	2012
The role of Tyk2 in regulation of breast cancer growth. Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research\| PubMed ID: 21864028	2011
Distinct signatures of the immune responses in low risk versus high risk neuroblastoma. Journal of translational medicine\| PubMed ID: 21978632	2011